spacer
home > pmps > summer 2016 > the long arm of the regulator
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Long Arm of the Regulator

As the appetite grows in Western markets for healthy, natural foods and supplements that contribute to wellness, the opportunity for nutraceuticals is soaring. Public demand for superfoods and enriched functional sustenance is at an all-time high, while government and health providers are also promoting illness prevention through healthier lifestyles and dietary choices.

A recent report from Transparency Market Research suggests that the global nutraceuticals market will expand at a 7.30% compound annual rate between now and 2021 Ė from $182.60 billion in 2015 to $278.96 billion in five years, not least as a way of bringing chronic diseases under control (1).

The pharmaceutical industry, looking for new opportunities to dilute its reliance on expensive blockbuster drugs, is embracing nutraceuticals through acquisition or expansion of businesses to include a nutrition-oriented division. But where operations and staff have come from outside the pharma sector, there are likely to be gaps in those businessesí understanding of the strict regulatory landscape they will be subject to.

Please see the full PDF for more details.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Peter Muller is Managing Director of Schlafender Hase (Americas). For the last 20 years, he has worked on software and process improvement projects with Fortune 500 companies from various industries: pharmaceutical, consumer goods, food, aerospace and defense. Peter has a wealth of experience working with international clients to define their organisationís goals and help them leverage new technologies to achieve productivity gains, process improvements and cost savings.
spacer
Peter Muller
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with the NASDAQ listed biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the companyís unique formulations using its proprietary in vitro models to optimise Novanís formulations and de-risk product development.
More info >>

White Papers

Pharmaceutical Companies: Outsourcing Combination Product Manufacturing

Phillips-Medisize

Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement